{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:27Z","timestamp":1761919527245},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T00:00:00Z","timestamp":1330041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Sickle cell anaemia (<jats:styled-content style=\"fixed-case\">SCA<\/jats:styled-content>) is a severe debilitating haematological disorder associated with a high degree of morbidity and mortality. The level of fetal haemoglobin (<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>) is well\u2010recognized as a critical laboratory parameter: lower <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> is associated with a higher risk of vaso\u2010occlusive complications, organ damage, and early death. Hydroxycarbamide treatment can induce <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>, improve laboratory parameters, and ameliorate clinical complications of <jats:styled-content style=\"fixed-case\">SCA<\/jats:styled-content> but its mechanisms of action remain incompletely defined and the <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> response is highly variable. To identify pathways of hydroxycarbamide activity, we performed microarray expression analyses of early reticulocyte <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> obtained from children with <jats:styled-content style=\"fixed-case\">SCA<\/jats:styled-content> enrolled in the HydroxyUrea Study of Long\u2010term Effects (<jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>00305175) and examined the effects of hydroxycarbamide exposure <jats:italic>in vivo<\/jats:italic>. Hydroxycarbamide affected a large number of erythroid genes, with significant decreases in the expression of genes involved in translation, ribosome assembly and chromosome organization, presumably reflecting the daily cytotoxic pulses of hydroxycarbamide. Hydroxycarbamide also affected expression of numerous genes associated with <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> including <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content><jats:italic>11A<\/jats:italic>, a key regulator of baseline <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> levels. Together, these data indicate that hydroxycarbamide treatment for <jats:styled-content style=\"fixed-case\">SCA<\/jats:styled-content> leads to substantial changes in erythroid gene expression, including <jats:styled-content style=\"fixed-case\">BCL<\/jats:styled-content><jats:italic>11<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content><\/jats:italic> and other potential signalling pathways associated with <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>b<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> induction.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09061.x","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T05:56:31Z","timestamp":1330062991000},"page":"240-248","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia"],"prefix":"10.1111","volume":"157","author":[{"given":"Jonathan M.","family":"Flanagan","sequence":"first","affiliation":[{"name":"International Hematology Center of Excellence Baylor College of Medicine Houston TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Steward","sequence":"additional","affiliation":[{"name":"Department of Hematology St. Jude Children's Research Hospital Memphis TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thad A.","family":"Howard","sequence":"additional","affiliation":[{"name":"International Hematology Center of Excellence Baylor College of Medicine Houston TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole A.","family":"Mortier","sequence":"additional","affiliation":[{"name":"International Hematology Center of Excellence Baylor College of Medicine Houston TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Kimble","sequence":"additional","affiliation":[{"name":"Department of Hematology St. Jude Children's Research Hospital Memphis TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Aygun","sequence":"additional","affiliation":[{"name":"Department of Hematology St. Jude Children's Research Hospital Memphis TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane S.","family":"Hankins","sequence":"additional","affiliation":[{"name":"Department of Hematology St. Jude Children's Research Hospital Memphis TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey A.","family":"Neale","sequence":"additional","affiliation":[{"name":"Hartwell Center for Bioinformatics and Biotechnology St. Jude Children's Research Hospital Memphis TN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[{"name":"International Hematology Center of Excellence Baylor College of Medicine Houston TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316672"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4454"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-5-p3"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.V56.6.1082.1082","article-title":"Quantitation of hemoglobins within individual red cells: asynchronous biosynthesis of fetal and adult hemoglobin during erythroid maturation in normal subjects","volume":"56","author":"Dover G.J.","year":"1980","journal-title":"Blood"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(81)90271-2"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.707"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.1.342"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03274.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2008.02.003"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1847"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.03.018"},{"key":"e_1_2_8_16_1","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG\u2010KIDS study, a phase I\/II trial","volume":"94","author":"Kinney T.R.","year":"1999","journal-title":"Pediatric Hydroxyurea Group. Blood"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb773"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.023325"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804799105"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.9778"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.06.090"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21699"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)01064-X"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221333"},{"key":"e_1_2_8_26_1","first-page":"2","article-title":"Advances in the use of hydroxyurea","volume":"6","author":"Ware R.E.","year":"2009","journal-title":"American Society of Hematology Education Program"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.1.10"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1897310"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.637"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2475"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09061.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09061.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:53:25Z","timestamp":1698728005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09061.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,24]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09061.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09061.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,24]]},"assertion":[{"value":"2011-08-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}